KAMPALA -- Ugandan scientists have launched the third phase of HIV vaccine efficacy trials in the central district of Masaka, the country's ministry of health said here Wednesday.
Emmanuel Ainebyoona, spokesperson for the ministry, told Xinhua that the Medical Research Council, the Uganda Virus Research Institute and the London School of Hygiene and Tropical Medicine have enrolled the first two volunteers in the African-led PrEPVacc HIV vaccine efficacy trials to test two ways of HIV prevention and pre-exposure prophylaxis in humans. (Uganda-HIV Vaccine)
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
